Masanori Nakakuki
Mochida Pharmaceutical (Japan)(JP)
Publications by Year
Research Areas
Cholesterol and Lipid Metabolism, Peroxisome Proliferator-Activated Receptors, Fatty Acid Research and Health, Lipid metabolism and biosynthesis, Cancer, Lipids, and Metabolism
Most-Cited Works
- → Polyunsaturated Fatty Acids Suppress Sterol Regulatory Element-binding Protein 1c Promoter Activity by Inhibition of Liver X Receptor (LXR) Binding to LXR Response Elements(2002)418 cited
- → Polyunsaturated Fatty Acids Ameliorate Hepatic Steatosis in Obese Mice by Srebp–1 Suppression(2003)403 cited
- → SREBPs suppress IRS-2-mediated insulin signalling in the liver(2004)315 cited
- → Cross-Talk between Peroxisome Proliferator-Activated Receptor (PPAR) α and Liver X Receptor (LXR) in Nutritional Regulation of Fatty Acid Metabolism. II. LXRs Suppress Lipid Degradation Gene Promoters through Inhibition of PPAR Signaling(2003)198 cited
- → Antiobesity Effect of Eicosapentaenoic Acid in High-Fat/High-Sucrose Diet–Induced Obesity(2010)159 cited
- → SREBP-1 Interacts with Hepatocyte Nuclear Factor-4α and Interferes with PGC-1 Recruitment to Suppress Hepatic Gluconeogenic Genes(2004)141 cited
- → Palmitate Impairs and Eicosapentaenoate Restores Insulin Secretion Through Regulation of SREBP-1c in Pancreatic Islets(2008)99 cited
- → Statins downregulate ATP-binding-cassette transporter A1 gene expression in macrophages(2004)58 cited
- → Lipid Synthetic Transcription Factor SREBP-1a Activates p21WAF1/CIP1, a Universal Cyclin-Dependent Kinase Inhibitor(2005)56 cited
- → Purification and some properties of delta-aminolevulinate synthase from the rat liver cytosol fraction and immunochemical identity of the cytosolic enzyme and the mitochondrial enzyme.(1980)43 cited